-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
September 01, 2011 - may increasingly
lead to long-term disease remission, there are many
unanswered questions about the safety … How do the efficacy, effectiveness,
safety, and adverse effects of treatment with DMARDs
differ among … How do the efficacy, effectiveness, Insufficient Only one study—an RCT of methotrexate versus
safety, … We did not identify any studies that
provide reliable information on the comparative
safety or rates
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-infertility_research.pdf
June 01, 2017 - The objectives of this SR are to evaluate
the comparative safety and effectiveness of treatment strategies … The KQs are listed below:
KQ 1: What are the comparative safety and effectiveness of available treatment … KQ 2: What are the comparative safety and effectiveness of available treatment strategies for
women … KQ 4: What are the comparative safety and effectiveness of available treatments for women with
tubal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_disposition-comments.pdf
March 01, 2012 - I think it is also
important to note that safety is UNCLEAR given sparse data and
lack of power. … Insufficient evidence compared between devices, and
safety remains unclear. … Safety, because of potential type II
error, is mostly unclear. … Due to type II
error, the safety of these devices is unclear.
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
January 01, 2014 - IL-1 may be a problematic target with respect to safety in the gout patient
population, however, and … and tolerability due to safety concerns over infections
reported in trials thus far. … These safety concerns may present barriers to approval or barriers
to diffusion if approved. … These safety concerns may
present significant barriers to approval and diffusion if approved. … SLE: belimumab safety, efficacy
sustained over 6 years. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-emergency_research-protocol.pdf
July 18, 2011 - Question 5
Does the effectiveness and safety of the parenteral pharmacological interventions vary … Question 6
Does the effectiveness and safety of adding parenteral or oral CSs to acute parenteral … Safety: RCTs, NRCTs, and prospective cohort studies. … Dodick D, Lipton RB, Martin V, et al, for the Triptan Cardiovascular Safety Expert Panel. … Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute
treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0352_09-22-2010.pdf
January 01, 2010 - depression treatment will be a good companion to an in-process AHRQ
EHC Program review titled Efficacy and Safety
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
June 01, 2015 - available at a discount, close to Federal Supply Schedule pricing, for colleges,
universities, public safety … have
unintended consequences, such as promoting continued opioid abuse by increasing the
perceived safety … Each device has
a sealed product indicator window; a removable needle safety guard; and the auto-injector … auto-injectors, the Evzio carton contains a “trainer” device, which
has an identical size, shape, and safety … solution to a reference product; a
user-experience study with adult and juvenile volunteers; and a safety
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/preterm-birth-terbutaline-pump_research-protocol.pdf
October 18, 2010 - such as
delay in delivery) are therefore common and meta-analyses are used to assess efficacy
and safety … Further, they
indicated that the lack of information on the safety of the treatment as well as the cost … Given the lack of efficacy, effectiveness, and safety data,
as well as substantial cost, it is clear … Finally, published
RCTs do not provide the necessary insight into questions regarding the safety of … Further,
observational studies have been identified that explore issues of terbutaline safety.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_executive.pdf
March 01, 2015 - Although
no salient long term benefits were identified, neither were
safety signals apparent. … Safety data are also needed for the broad
array of herbs and botanicals used to treat menopausal
symptoms … and efficacy, but the
manufacturers are not required to submit the safety or
efficacy data to FDA. … Although the gap is most concerning regarding safety,
efficacy issues are important as well. … some nonhormone therapies, with reasonable certainty
(i.e., moderate or greater SOE), significant safety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/management-adhd-adults-protocol.pdf
June 10, 2024 - adherence.96, 106-108
Purpose of the Review
This systematic review will assess the comparative safety … How do comparative safety and effectiveness vary by patient characteristics,
such as age, sex/gender … Safety of therapeutic methylphenidate in adults: a systematic review of the
evidence. … Safety and tolerability of once versus twice daily
atomoxetine in adults with ADHD. … Efficacy, safety and variability in pharmacotherapy for
adults with attention deficit hyperactivity
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/management-adhd-adults-protocol-amendment.pdf
January 08, 2025 - adherence.96, 106-108
Purpose of the Review
This systematic review will assess the comparative safety … How do comparative safety and effectiveness vary by patient characteristics,
such as age, sex, race, … Safety of therapeutic methylphenidate in adults: a systematic review of the
evidence. … Safety and tolerability of once versus twice daily
atomoxetine in adults with ADHD. … Efficacy, safety and variability in pharmacotherapy for
adults with attention deficit hyperactivity
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_disposition-comments.pdf
January 01, 2010 - Further,
small studies [Phase I (safety); Phase II (dose-
ranging; mechanistic)] may show effects which … subcutaneous
immunotherapy, there are few studies of SLIT in
moderate or severe asthmatics, and the safety … off label use of licensed
products for SLIT by physicians who are falsely
comforted by the current safety … The mandate of this AHRQ report is to provide
evidence for the effect and safety of allergen
immunotherapy … controlled European clinical trials that
demonstrated clinical efficacy and a sufficient
degree of safety
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_5-user-guide-to-ocer_130129.pdf
January 01, 2012 - A comparison between aripiprazole,
an antipsychotic agent with a relatively favorable
metabolic safety … data
sources can be linked to enhance the validity
of observational comparative effectiveness and
safety … same indication does not necessarily remove
confounding by severity.21
For clinical effectiveness or safety … comparators, as explained in the previous section,
are generally more appropriate, particularly for
safety … appropriate
when comparing two treatments with expected
differences in the timing of beneficial or safety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adult-treatment_disposition-comments.pdf
April 03, 2013 - …"
a) Seeking Safety (SS) was designed for both genders. … The
relevant paragraph was (and
still is) in the Seeking Safety
results section titled
Prevention … We agree that this study has
some limitations that limit what
we can conclude about
seeking safety … Further
studies would be needed to
determine whether seeking
safety is efficacious for
improving … We also changed it to “seeking
safety” rather than “safety
seeking” to be consistent with
wording
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
June 01, 2010 - It is unfair to label all companies as profit-driven over safety-
driven. … Further, this trial was designed primarily as a safety and proof-of-
concept trial. … Unfortunately, the two
large, randomized controlled trials on the efficacy and safety of rFVIIa
in … Efficacy and safety of
recombinant activated factor VII for acute intracerebral
hemorrhage. … Safety and feasibility of
recombinant factor VIIa for acute intracerebral hemorrhage.
-
effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
January 01, 2012 - significantly increased the regulatory bar for gaining approval—specifically
regarding preapproval safety … data and postmarket safety evaluation—set forth by the U.S. … Kushner and colleagues announced results from a phase III clinical trial (SEQUEL)
evaluating the safety … 2011, Allison and colleagues announced results from a 56-week clinical trial (EQUIP)
evaluating the safety … Safety and efficacy study of
EndoBarrier in subjects with type II diabetes and
obesity.
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
October 30, 2012 - The varying
definitions of MACE included one related to
safety only [composite of death, MI, and stent … thrombosis (ST)], and two relating to both safety
and effectiveness [composite of death, MI, ST, … The safety-only definition of MACE
yielded a hazard ratio of 1.75 (p<0.05), indicating
that patients … However, for the composite
of safety and effectiveness endpoints, the risk
of 1-year MACE was greatly … For example, once a safety signal has
been identified and publicized, physicians have
been alerted
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
October 29, 2012 - • There are no safety concerns
Summary Decision:
This CER’s priority for updating is Low … magnitude/direction of changes
in estimates, potential changes in practice or therapy preference, safety … Safety surveillance alerts: None
Conclusion: Up to date
Key Questions # 2
Signals from studies … Safety surveillance alerts: None
Conclusion: 5/11 conclusions are possibly out of date
17 … Efficacy
and
safety
of
oxybutynin
chloride
topical
gel
for
women
with
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0265_02-29-2008.pdf
January 01, 2008 - How do the effectiveness and safety of pharmacologic and nonpharmacologic pain management
interventions
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2021.pdf
January 01, 2021 - National Highway Traffic Safety Administration
funding opportunity on airway management
(2021)
Prehospital … Safety of Vaccines Used for Routine Immunization in the United States: An Update
DOI: 10.23970/AHRQEPCCER244 … Safety of vaccines used for routine immunization in the
United States: An updated systematic review … National Highway Traffic Safety Administration (NHTSA)
5. … Agency for Healthcare Research and Quality (AHRQ) - Center for Quality Improvement and Patient
Safety